1. Simmons, Daimon P, Nguyen, Hung N, Gomez-Rivas, Emma, Kim, Edy Y, Brenner, Michael B. 2022. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. In Science immunology, 7, eabf2846. doi:10.1126/sciimmunol.abf2846. https://pubmed.ncbi.nlm.nih.gov/35148199/
2. Deng, Yalong, Zhang, Lu, Dai, Changyuan, Gan, Qiyu, Cheng, Jingxin. 2024. SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma. In Journal of gynecologic oncology, 35, e79. doi:10.3802/jgo.2024.35.e79. https://pubmed.ncbi.nlm.nih.gov/38606823/
3. O'Connell, Patrick, Blake, Maja K, Godbehere, Sarah, Amalfitano, Andrea, Aldhamen, Yasser A. 2022. SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity. In Journal of neuroinflammation, 19, 241. doi:10.1186/s12974-022-02594-9. https://pubmed.ncbi.nlm.nih.gov/36199066/
4. Prommersberger, Sabrina, Reiser, Michael, Beckmann, Julia, Bonig, Halvard, Ivics, Zoltán. 2021. CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma. In Gene therapy, 28, 560-571. doi:10.1038/s41434-021-00254-w. https://pubmed.ncbi.nlm.nih.gov/33846552/
5. van de Donk, Niels W C J, Usmani, Saad Z, Yong, Kwee. . CAR T-cell therapy for multiple myeloma: state of the art and prospects. In The Lancet. Haematology, 8, e446-e461. doi:10.1016/S2352-3026(21)00057-0. https://pubmed.ncbi.nlm.nih.gov/34048683/
6. O'Connell, Patrick, Hyslop, Sean, Blake, Maja K, Amalfitano, Andrea, Aldhamen, Yasser A. 2020. SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment. In Journal of immunology (Baltimore, Md. : 1950), 206, 193-205. doi:10.4049/jimmunol.2000300. https://pubmed.ncbi.nlm.nih.gov/33288545/
7. Roders, Nathalie, Nakid-Cordero, Cecilia, Raineri, Fabio, Arnulf, Bertrand, Bories, Jean-Christophe. . Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma. In Cancer immunology research, 12, 478-490. doi:10.1158/2326-6066.CIR-23-0839. https://pubmed.ncbi.nlm.nih.gov/38289260/